Five-Reasons-to-Embrace-Data-Driven-Drug-Development

Five Reasons to Embrace Data-Driven Drug Development

Life Science / By

The growth of the pharmaceutical and biotechnology industry depends on successful clinical trials. The cost of developing a new drug that gets approval is estimated at around $2-3 billion. The longer the trial lasts and the more patients it has involved, the larger the loss. The researchers at Johns Hopkins Bloomberg School of Public Health …

Five Reasons to Embrace Data-Driven Drug Development Read More »